Skip to main content
. 2020 Sep 1;22(9):e21758. doi: 10.2196/21758

Figure 1.

Figure 1

Baseline comorbidities and medication use in the hydroxychloroquine (HCQ) group, tocilizumab (TCZ) group, and control groups. The x-axis represents sex, comorbidities, medications, C-reactive protein (CRP), and D-dimer level at presentation; the y-axis represents the percentage of subjects. DM: diabetes mellitus; HTN: hypertension; CKD: chronic kidney disease; CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; AC: anticoagulation.